Members
-
Embryonic stem cells, induced pluripotent stem cells
-
Naive and Primed Pluripotency
-
Artificial embryo, Blastoid
-
Disease modeling for genetic disorder research
-
In vivo gene/cell therapy
-
Distinctive characteristic of ferroptosis in stem cells
-
Molecular mechanism of liver regeneration
-
Epigenetic regulation upon cellular dedifferentiation
-
Development of regenerative medicine
-
Disease modeling and drug discovery by using gene editing tools with PSCs.
-
Finding a new therapeutic strategy for genetic disease.
-
DNA damage repair and Cas9 gene editing
-
Embryonic stem cells, induced pluripotent stem cells
-
Naive and Primed Pluripotency
-
Artificial embryo, Blastoid
-
Epigenetic regulation during early embryogenesis
-
First lineage specification
-
Embryology
-
Developmental biology
-
In Vivo Partial Reprogramming for Melanocyte Lineage Regeneration
-
Precise Genome Editing for Therapeutic Induction of Beneficial Mutations
-
Cell and gene therapy
-
Disease modeling
-
Dissecting cell-cycle regulation and lineage specification during development using stem cell–based models
-
Mechanisms of Liver Reprogramming in Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
-
In Vivo Tumor Microenvironment Modeling Using Stem Cell–Derived Teratomas
-
In vivo reprogramming in stomach and molecular mechanism of gastric regeneration
-
Intestinal aging and regenerative therapy
-
In vivo reprogramming in bone marrow and HSCs
-
Blood epigenetic clock reversal by hematopoietic reprogramming
-
Exploring the world of science...
-
Disease in a dish modeling
-
Gene-edited disease modeling
-
Site-specific large gene insertion
-
Gene editing tool development
-
RNA editing
-
3D disease modeling
-
AI-driven gene therapy